HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

DNA analysis in patients with lissencephaly type I and other cortical dysplasias.

Abstract
DNA markers YNZ22.1, YNH37.3, 144D6, and VAW508 were studied in five patients with the Miller-Dieker syndrome, 17 patients with the isolated lissencephaly sequence, one patient with a non-classified lissencephaly, and nine patients with an atypical cortical dysplasia. All patients had normal chromosomes except for a deletion 17p13.3 in one of the five Miller-Dieker patients. The five Miller-Dieker patients showed deletions of markers YNZ22.1 and YNH37.3 in contrast to the other patients tested. In one patient, the deletion was in the maternally contributed chromosome. Prenatal diagnosis by DNA analysis allowed exclusion of the recurrence of Miller-Dieker syndrome in a subsequent pregnancy.
AuthorsB A Oostra, J F de Rijk-van Andel, H J Eussen, J O van Hemel, D J Halley, M F Niermeijer
JournalAmerican journal of medical genetics (Am J Med Genet) Vol. 40 Issue 3 Pg. 383-6 (Sep 01 1991) ISSN: 0148-7299 [Print] United States
PMID1951447 (Publication Type: Journal Article)
Chemical References
  • DNA Probes
  • DNA
Topics
  • Brain (abnormalities)
  • Cells, Cultured
  • Chromosome Deletion
  • Chromosomes, Human, Pair 17
  • DNA (isolation & purification)
  • DNA Probes
  • Female
  • Humans
  • Karyotyping
  • Male
  • Pedigree
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: